Table of Contents

1. Introduction

2. Drug-induced anagen effluvium

3. Drug-induced telogen effluvium

4. Table: Some drugs that may cause hair loss

Introduction

Some drugs may cause hair loss by interfering with the cycle of hair growth.

Each hair follicle cycles through the following main phases:

  • Anagen phase (hair is actively growing),
  • Catagen phase (a transitional phase), and
  • Telogen phase (the resting phase, followed by shedding of hair).

Diagram of hair growth cycle showing three phases: anagen, catagen and telogen

The two types of hair loss attributable to a drug are anagen effluvium and telogen effluvium. Fortunately, these types of drug-induced alopecias are generally reversible once the offending drug is stopped in the patient.

Drug-induced anagen effluvium

  • Some drugs may interrupt the anagen phase (when the hair is actively growing) of the cycle of hair growth and thereby cause the loss of hair.
  • It is most commonly associated with cytotoxic drugs.
  • Anagen effluvium is a form of non-scarring alopecia.
  • Hair loss begins soon after the drug is administered.
  • In most cases, hair loss is reversible once drug treatment is stopped, but it can take a few weeks for regrowth to begin.

Drug-induced telogen effluvium

  • Some drugs may interfere with the telogen phase (shedding of the hair) of the cycle of hair growth and thus cause more hairs than normal to be shed; this results in thinning of the hair.
  • Some drugs that have been implicated in drug-induced telogen effluvium are isotretinoin and statins.
  • Hair loss occurs 2-4 months after initiation of the drug causing alopecia.
  • Telogen effluvium is a form of non-scarring alopecia with diffuse hair loss.
  • Telogen effluvium may not be noticed by the patient immediately.
  • In most cases, hair loss is reversible once drug treatment is stopped and resolves spontaneously.

Table: Drugs causing alopecia

Here is a list of some drugs that may cause drug-induced alopecia.

Table: Some drugs that may cause hair loss

Drugs that may cause hair loss

Antiepileptics e.g. levetiracetam, oxcarbazepine, sodium valproate

Antivirals e.g. didanosine, lamivudine, saquinavir, cidofovir, entecavir

Antiarrhythmics e.g. flecainide

Anticoagulants e.g. warfarin, acenocoumarol, heparin

Antipsychotics e.g. olanzapine, risperidone, lithium

Antidepressants e.g. citalopram, fluoxetine, sertraline

Antifungals e.g. itraconazole, ketoconazole, voriconazole

Antimalarials e.g. mefloquine

Antithyroid drugs e.g. carbimazole, propylthiouracil

Aromatase inhibitors e.g. anastrozole, exemestane

Beta-blockers

Cytotoxic drugs

Disease-modifying anti-rheumatic drugs e.g. leflunomide, hydroxychloroquine sulfate, sodium aurothiomalate

Excess vitamin a

Fibrates e.g. bezafibrate, ciprofibrate

Immunosuppressants e.g. mycophenolate mofetil, tacrolimus

Interferons e.g. interferon beta, peginterferon alfa

Oral contraceptives

Retinoids e.g. acitretin, isotretinoin, alitretinoin

Anti-estrogens e.g. Tamoxifen

Statins e.g. atorvastatin, pravastatin, simvastatin

Betaine

Bicalutamide

Exenatide

Stontium ranelate

Mexiletine

Bromocriptine

Levodopa

Source: References 1-31

 

References

1. Accord Healthcare Limited. Olanzapine 10 mg Film-coated Tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/6082/smpc [Accessed on 23/10/19].

2. ADVANZ Pharma. Ciprofibrate 100mg Tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/4997/smpc [Accessed on 23/10/19].

3. Aurobindo Pharma – Milpharm Ltd. Pravastatin sodium 10 mg tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/5321/smpc [Accessed on 23/10/19].

4. Consilient Health Ltd. Atorvastatin 10 mg film-coated tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/2959/smpc [Accessed on 23/10/19].

5. Endo Ventures Limited. Fluoxetine 10 mg Film-coated Tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/9338/smpc [Accessed on 23/10/19].

6. Ennogen Healthcare Ltd. Alitretinoin 30mg soft capsules – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/10466/smpc [Accessed on 23/10/19].

7. Essential Pharma Ltd. Camcolit 400 mg, controlled release Lithium Carbonate – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/10829/smpc [Accessed on 23/10/19].

8. Flamingo Pharma (UK) Ltd. Carbimazole 5 mg Tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/10156/smpc [Accessed on 23/10/19].

9. Janssen-Cilag Ltd. Risperdal 1 mg Film-Coated Tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/6857/smpc [Accessed on 23/10/19].

10. Lundbeck Limited. Cipramil Tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/992/smpc [Accessed on 23/10/19].

11. Lupin Healthcare (UK) Ltd. Simvador 40 mg Tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/7167/smpc [Accessed on 23/10/19].

12. Merus Labs Luxco II S.à R.L. Sinthrome 1 mg Tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/2058 [Accessed on 23/10/19].

13. Mylan. Flecainide acetate 100mg Tablets– Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/8157/smpc [Accessed on 23/10/19].

14. Mylan. Oxcarbazepine 150 mg film-coated tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/8483 [Accessed on 23/10/19].

15. National Center for Biotechnology Information. PubChem Database. Acenocoumarol, CID=54676537. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Acenocoumarol [Accessed on 23/10/19].

16. National Center for Biotechnology Information. PubChem Database. Didanosine, CID=135398739. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Didanosine [Accessed on 23/10/19].

17. National Center for Biotechnology Information. PubChem Database. Itraconazole, CID=3793. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Itraconazole [Accessed on 23/10/19].

18. National Center for Biotechnology Information. PubChem Database. Lamivudine, CID=60825. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Lamivudine [Accessed on 23/10/19].

19. National Center for Biotechnology Information. PubChem Database. Leflunomide, CID=3899. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Leflunomide [Accessed on 23/10/19].

20. National Center for Biotechnology Information. PubChem Database. Levetiracetam, CID=5284583. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Levetiracetam [Accessed on 23/10/19].

21. National Center for Biotechnology Information. PubChem Database. Mefloquine, CID=4046. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Mefloquine [Accessed on 23/10/19].

22. National Center for Biotechnology Information. PubChem Database. Propylthiouracil, CID=657298. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Propylthiouracil [Accessed on 23/10/19].

23. National Center for Biotechnology Information. PubChem Database. Saquinavir, CID=441243. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Saquinavir [Accessed on 23/10/19].

24. National Center for Biotechnology Information. PubChem Database. Sodium valproate, CID=16760703. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Sodium-valproate [Accessed on 23/10/19].

25. National Center for Biotechnology Information. PubChem Database. Sertraline, CID=68617. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Sertraline [Accessed on 23/10/19].

26. National Center for Biotechnology Information. PubChem Database. Tacrolimus, CID=445643. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Tacrolimus [Accessed on 23/10/19].

27. National Center for Biotechnology Information. PubChem Database. Xolegel, CID=456201. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Xolegel [Accessed on 23/10/19].

28. Roche Products Limited. Cellcept 250mg Capsules – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/1102/smpc [Accessed on 23/10/19].

29. Sandoz Limited. Fibrazate XL 400 mg Modified Release Tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/6547 [Accessed on 23/10/19].

30. Teva UK Limited. Acitretin (Neotigason) 10mg Capsules – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/10248/smpc [Accessed on 23/10/19].

31. Zentiva. Plaquenil-Hydroxychloroquine sulfate 200mg Film-coated Tablets – Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/1764/smpc [Accessed on 23/10/19].

Print Print